SYNE1 Gene Spinocerebellar Ataxia Type 8 Autosomal Recessive Genetic Test
Are you concerned about Spinocerebellar Ataxia Type 8 (SCA8)? DNA Labs UAE offers a comprehensive genetic test to identify mutations or variations in the SYNE1 gene that may be associated with the development of SCA8. Our advanced Next-generation sequencing (NGS) technology allows us to analyze multiple genes simultaneously, providing accurate and reliable results.
Test Details
The SYNE1 gene is associated with Spinocerebellar Ataxia Type 8 (SCA8), an autosomal dominant neurodegenerative disorder that affects the cerebellum and spinal cord. Although SCA8 is typically inherited in an autosomal dominant manner, our genetic test can help identify potential mutations or variations in the SYNE1 gene.
Test Name: SYNE1 Gene Spinocerebellar Ataxia Type 8 Autosomal Recessive Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Before undergoing the SYNE1 Gene Spinocerebellar Ataxia Type 8 Autosomal Recessive Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by SCA8. This will help us understand the inheritance pattern and provide accurate results.
Consult a Healthcare Professional
It is crucial to consult with a healthcare professional or a genetic counselor for accurate and comprehensive information about genetic testing for SCA8. They can provide detailed insights into the testing process, its limitations, and the implications of the test results. Our team of experienced neurologists and geneticists is here to support you throughout the testing process and provide the necessary guidance.
Don’t let uncertainties about SCA8 weigh you down. Contact DNA Labs UAE today to schedule your SYNE1 Gene Spinocerebellar Ataxia Type 8 Autosomal Recessive Genetic Test and take control of your health.
Test Name | SYNE1 Gene Spinocerebellar ataxia type 8 autosomal recessive Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SYNE1 Gene Spinocerebellar ataxia type 8, autosomal recessive NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SYNE1 Gene Spinocerebellar ataxia type 8, autosomal recessive |
Test Details |
The SYNE1 gene is associated with Spinocerebellar Ataxia Type 8 (SCA8), an autosomal dominant neurodegenerative disorder that affects the cerebellum and spinal cord. However, it is important to note that SCA8 is typically inherited in an autosomal dominant manner, not autosomal recessive. Next-generation sequencing (NGS) genetic tests are a type of genetic test that can analyze multiple genes simultaneously. In the context of SCA8, an NGS genetic test can be used to identify mutations or variations in the SYNE1 gene that may be associated with the development of SCA8. However, it is crucial to consult with a healthcare professional or a genetic counselor for accurate and comprehensive information about genetic testing for SCA8. They can provide detailed insights into the testing process, its limitations, and the implications of the test results. |